The blaSHV gene, detected in the Urinary Tract Infection Panel by RealTime Laboratories, is a significant marker for antibiotic resistance, particularly in urinary tract infections (UTIs). This gene encodes the SHV type beta-lactamase, an enzyme that confers resistance to beta-lactam antibiotics, a class that includes penicillins and cephalosporins. The presence of the blaSHV gene in UTI-causing bacteria is a critical factor in determining the appropriate antibiotic treatment, as it indicates that the bacteria may be resistant to commonly used antibiotics in this class.
Beta-lactamases like SHV are enzymes produced by bacteria that provide resistance by breaking down the beta-lactam ring, a core structure in the molecular composition of these antibiotics. This action renders the antibiotic ineffective, allowing the bacteria to survive and proliferate despite the presence of the drug. The blaSHV gene variants have been identified in various bacterial species, with some strains showing enhanced activity or resistance against advanced cephalosporins.
In clinical settings, the detection of blaSHV is crucial for guiding effective antibiotic therapy. If a UTI-causing bacterium is found to carry this gene, healthcare providers may opt for alternative treatments that are effective against beta-lactamase-producing organisms. The identification of antibiotic resistance genes, like blaSHV, is an integral part of antibiotic stewardship programs, aiming to optimize the use of antibiotics, reduce the spread of resistance, and improve patient outcomes.
blaSHV
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.